Drug profile · INN
lefamulin acetate
XENLETA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
lefamulin acetate (XENLETA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN lefamulin acetate
Brand XENLETA
Route ORAL
Formulation SOLUTION
Frequently asked questions
What is lefamulin acetate?
lefamulin acetate (XENLETA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for lefamulin acetate?
XENLETA is a marketed brand name for lefamulin acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of lefamulin acetate?
lefamulin acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.